In The Know-August 2026

August 2026
Pdf Summary
This August 2026 “Ed’s List” highlights several important gynecologic oncology publications and themes:

- <strong>Cervical cancer prevention:</strong> A large U.S. study found that the proportion of women who have <strong>never been screened for cervical cancer is rising</strong>, especially among younger women and underserved groups. This increase parallels <strong>more advanced cervical cancer diagnoses</strong>, reinforcing the need for targeted screening and HPV vaccination efforts.

- <strong>Ovarian cancer therapeutics and biology:</strong> Multiple studies focused on ovarian cancer. A major retrospective cohort showed that patients with <strong>exceptional long-term responses to PARP inhibitors</strong> often remain progression-free even after stopping therapy, with a <strong>low risk of late MDS/AML</strong>, raising the possibility of functional cure in some patients. Another multicenter study found that <strong>secondary cytoreductive surgery</strong> at high-volume centers, when complete gross resection is achieved, is associated with <strong>substantially longer survival</strong> than chemotherapy alone. Spatial transcriptomic work mapped <strong>tumor progression and immune evasion</strong> mechanisms in high-grade serous ovarian cancer. Early-phase device and immunotherapy studies tested a <strong>replenishable peritoneal implant</strong> for repeated therapy delivery and a <strong>first-in-human IL-2 encapsulated cell therapy</strong>, both aimed at improving locoregional treatment.

- <strong>Immune and translational science:</strong> New preclinical work described <strong>engineered iPSC-derived dendritic cells “dressed” with tumor MHC complexes</strong> as a scalable cancer vaccine platform. Another study identified a <strong>Gdf15-AhR axis</strong> that may contribute to NK-cell dysfunction in “cold” ovarian tumors under environmental stress.

- <strong>Endometrial cancer disparities and diagnostics:</strong> One study found <strong>larger Black-White survival disparities in endometrial cancer among patients under 65</strong>, with aggressive histology and distant disease explaining part, but not all, of the gap. Another showed that <strong>transvaginal ultrasound completion is lower in Black women mainly due to fibroids</strong>, though diagnostic accuracy remains high when imaging is completed. A biomarker study suggested <strong>cervicovaginal lipid profiles</strong> may aid minimally invasive endometrial cancer detection.

- <strong>Hereditary cancer and pathology:</strong> Deeper sectioning and AI-assisted review improved detection of occult <strong>STIC/HGSC lesions</strong> in RRSO specimens from BRCA carriers, supporting a tubal origin for some peritoneal HGSC. Multi-omics analyses also identified <strong>novel susceptibility factors</strong> in suspected HBOC cases.

- <strong>AI in cancer care:</strong> Two articles emphasized that patient-facing online information about AI in cancer care is <strong>low quality, hard to read, and often omits safety concepts</strong>, underscoring the need for patient AI literacy.
Keywords
gynecologic oncology
cervical cancer screening
HPV vaccination
ovarian cancer therapeutics
PARP inhibitors
secondary cytoreductive surgery
tumor immune evasion
endometrial cancer disparities
hereditary cancer pathology
AI in cancer care